CME Group Q2 2026: flat revenue, small EPS beat as volumes slip
CME Group's Q2 2026 was solid but not a step forward: revenue of $1.71 billion rose 0.8% year over year, adjusted EPS of $2.99 edged past the $2.94 consensus, and volumes actually fell. Read it as a mix story — record market data revenue and collateral-driven investment income are carrying a quarter in which clearing fees slipped 2.6%. The sequential drop from Q1's $1.88 billion is the part worth your attention.
1 · Expected vs. Actual
Free preview belowGAAP diluted EPS was $2.88 and adjusted EPS was $2.99, against a $2.94 consensus — a beat of about 1.8%. Net income of $1.04 billion was roughly flat year over year, and operating income actually fell 2.0% to $1.11 billion. The gap between GAAP and adjusted figures comes mostly from $56 million of purchased-intangible amortization and $6 million of restructuring and severance.
Revenue came in at $1.71 billion, up 0.8% from $1.69 billion a year ago but down 9.2% from Q1 2026's $1.88 billion. The mix is the story: market data hit a record $238 million, up 20.2%, while clearing and transaction fees — 79.3% of revenue — fell 2.6% to $1.35 billion. Average daily volume of 29.84 million contracts was down 1.2% and the average rate per contract slipped to $0.678 from $0.690.
Log in to read 35 analyses a week for free
Create a free account to read 35 full earnings analyses each week — all five steps: expected vs. actual, guidance tracker, money flow, balance sheet and risks. Members get unlimited access.
Figures on this page come from the company's original SEC filings. The analysis is generated automatically and checked against validation rules, but may still contain errors or omissions. Not investment advice. · Generated 2026-09-17
Answers are based on the earnings release and the analysis above. Free accounts get 3 questions a week; members get 30 a day.